Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 271

1.

Prevalence of Injecting Drug Use and Coverage of Interventions to Prevent HIV and Hepatitis C Virus Infection Among People Who Inject Drugs in Canada.

Jacka B, Larney S, Degenhardt L, Janjua N, Høj S, Krajden M, Grebely J, Bruneau J.

Am J Public Health. 2019 Nov 14:e1-e6. doi: 10.2105/AJPH.2019.305379. [Epub ahead of print]

PMID:
31725310
2.

Surveillance summary of hospitalized pediatric enterovirus D68 cases in Canada, September 2014.

Edwin JJ, Domingo FR, Booth TF, Mersereau T, Skowronski DM, Chambers C, Simmonds K, Scott AN, Winter AL, Peci A, Gubbay J, Drews SJ, Krajden M, Karnauchow T, Smieja M, Rempel S, Murti M, Pollock S, Gustafson R, Hoyano D, Allison S, Fathima S, Pabbaraju K, Wong S, Tellier R, Tipples G, Gad RR, Mukhi SN, Jafari Y, Grudeski E, McDermid A, Wong T.

Can Commun Dis Rep. 2015 Feb 20;41(Suppl 1):2-8. doi: 10.14745/ccdr.v41is1a01. eCollection 2015 Feb 20.

PMID:
31713547
3.

Loss to follow-up: a significant barrier in the treatment cascade with direct-acting therapies.

Darvishian M, Wong S, Binka M, Yu A, Ramji A, Yoshida EM, Wong J, Rossi C, Butt ZA, Bartlett S, Pearce ME, Samji H, Cook D, Alvarez M, Chong M, Tyndall M, Krajden M, Janjua NZ.

J Viral Hepat. 2019 Oct 30. doi: 10.1111/jvh.13228. [Epub ahead of print]

PMID:
31664755
4.

Reply to: "Pitfalls in measuring temporal trends for late diagnosis of viral hepatitis".

Wilton J, Samji H, Yu A, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort team.

J Hepatol. 2019 Oct 22. pii: S0168-8278(19)30553-7. doi: 10.1016/j.jhep.2019.09.015. [Epub ahead of print] No abstract available.

PMID:
31653445
5.

Immunogenicity of 2 and 3 Doses of the Quadrivalent Human Papillomavirus Vaccine up to 120 Months Postvaccination: Follow-up of a Randomized Clinical Trial.

Donken R, Dobson SRM, Marty KD, Cook D, Sauvageau C, Gilca V, Dionne M, McNeil S, Krajden M, Money D, Kellner J, Scheifele DW, Kollmann T, Bettinger JA, Liu S, Singer J, Naus M, Sadarangani M, Ogilvie GS.

Clin Infect Dis. 2019 Sep 6. pii: ciz887. doi: 10.1093/cid/ciz887. [Epub ahead of print]

PMID:
31617568
6.

Association between meteorological variations and activities of influenza A and B across different climate zones: A multi-region modelling analysis across the globe.

Chong KC, Lee TC, Chen J, Choy WSC, Krajden M, Jalal H, Jennings L, Alexander B, Lee HK, Fraaij P, Levy A, Yeung ACM, Tozer S, Lau SYF, Jia KM, Tang JWT, Hui DSC, Chan PKS.

J Infect. 2019 Oct 1. pii: S0163-4453(19)30284-1. doi: 10.1016/j.jinf.2019.09.013. [Epub ahead of print]

PMID:
31580867
7.

Cervical intraepithelial neoplasia rates in British Columbia women: A population level data linkage evaluation of the school-based HPV immunization program.

Racey CS, Albert A, Donken R, Smith L, Spinelli JJ, Pedersen H, de Bruin P, Masaro C, Mitchell-Foster S, Sadarangani M, Dawar M, Krajden M, Naus M, van Niekerk D, Ogilvie G.

J Infect Dis. 2019 Aug 23. pii: jiz422. doi: 10.1093/infdis/jiz422. [Epub ahead of print]

PMID:
31504649
8.

A cohort study comparing rate of repeat testing for sexually transmitted and blood-borne infections between clients of an internet-based testing programme and of sexually transmitted infection clinics in Vancouver, Canada.

Gilbert M, Salway T, Haag D, Elliot E, Fairley C, Krajden M, Grennan T, Shoveller J, Ogilvie GS.

Sex Transm Infect. 2019 Nov;95(7):540-546. doi: 10.1136/sextrans-2019-054071. Epub 2019 Aug 29.

9.

The population level care cascade for hepatitis C in British Columbia, Canada as of 2018: Impact of direct acting antivirals.

Bartlett SR, Yu A, Chapinal N, Rossi C, Butt Z, Wong S, Darvishian M, Gilbert M, Wong J, Binka M, Alvarez M, Tyndall M, Krajden M, Janjua NZ.

Liver Int. 2019 Aug 24. doi: 10.1111/liv.14227. [Epub ahead of print]

PMID:
31444846
10.

Sustained virological response from interferon-based hepatitis C regimens is associated with reduced risk of extrahepatic manifestations.

Rossi C, Jeong D, Wong S, McKee G, Butt ZA, Buxton J, Wong J, Darvishian M, Bartlett S, Samji H, Yu A, Binka M, Alvarez M, Adu PA, Tyndall M, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort Team.

J Hepatol. 2019 Aug 6. pii: S0168-8278(19)30462-3. doi: 10.1016/j.jhep.2019.07.021. [Epub ahead of print]

PMID:
31433302
11.

Comparative global epidemiology of influenza, respiratory syncytial and parainfluenza viruses, 2010-2015.

Lam TT, Tang JW, Lai FY, Zaraket H, Dbaibo G, Bialasiewicz S, Tozer S, Heraud JM, Drews SJ, Hachette T, Chan PK, Koay ES, Lee HK, Tee KK, Liu Y, Fraaij P, Jennings L, Waris M, Krajden M, Corriveau A, Jalal H, Nishimura H, Nymadawa P, Badarch D, Watanabe A, Kabanda A, Sloots T, Kok J, Dwyer DE, Koopmans M; INSPIRE (International Network for the Sequencing of Respiratory Viruses).

J Infect. 2019 Oct;79(4):373-382. doi: 10.1016/j.jinf.2019.07.008. Epub 2019 Jul 16.

PMID:
31323249
12.

Disease detection at the 48-month exit round of the HPV FOCAL cervical cancer screening trial in women per-protocol eligible for routine screening.

Coldman AJ, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan DJ, Lee M, Elwood-Martin R, Gentile L, Peacock S, Stuart GCE, Franco EL, Ogilvie GS.

Int J Cancer. 2019 Jun 27. doi: 10.1002/ijc.32524. [Epub ahead of print]

PMID:
31245842
13.

What is killing people with hepatitis C virus infection? Analysis of a population-based cohort in Canada.

Krajden M, Cook DA, Wong S, Yu A, Butt ZA, Rossi C, Darvishian M, Alvarez M, Buxton JA, Tyndall M, Janjua NZ.

Int J Drug Policy. 2019 Oct;72:114-122. doi: 10.1016/j.drugpo.2019.06.003. Epub 2019 Jun 20.

PMID:
31229445
14.

Syndemic Characterization of HCV, HBV, and HIV Co-infections in a Large Population Based Cohort Study.

McKee G, Butt ZA, Wong S, Salway T, Gilbert M, Wong J, Alvarez M, Chapinal N, Darvishian M, Tyndall MW, Krajden M, Janjua NZ.

EClinicalMedicine. 2018 Nov 5;4-5:99-108. doi: 10.1016/j.eclinm.2018.10.006. eCollection 2018 Oct-Nov.

15.

Children under 10 years of age were more affected by the 2018/19 influenza A(H1N1)pdm09 epidemic in Canada: ‎possible cohort effect following the 2009 influenza pandemic.

Skowronski DM, Leir S, De Serres G, Murti M, Dickinson JA, Winter AL, Olsha R, Croxen MA, Drews SJ, Charest H, Martineau C, Sabaiduc S, Bastien N, Li Y, Petric M, Jassem A, Krajden M, Gubbay JB.

Euro Surveill. 2019 Apr;24(15). doi: 10.2807/1560-7917.ES.2019.24.15.1900104.

16.

Medical Information Commons to Support Learning Healthcare Systems: Examples From Canada.

Bubela T, Genuis SK, Janjua NZ, Krajden M, Mittmann N, Podolak K, Svenson LW.

J Law Med Ethics. 2019 Mar;47(1):97-105. doi: 10.1177/1073110519840488.

PMID:
30994059
17.

Effectiveness of Ledipasvir/Sofosbuvir and Sofosbuvir/Velpatasvir in People Who Inject Drugs and/or Those in Opioid Agonist Therapy.

Janjua NZ, Darvishian M, Wong S, Yu A, Rossi C, Ramji A, Yoshida EM, Butt ZA, Samji H, Chong M, Chapinal N, Cook D, Alvarez M, Tyndall M, Krajden M; British Columbia Hepatitis Testers Cohort Team.

Hepatol Commun. 2019 Jan 10;3(4):478-492. doi: 10.1002/hep4.1307. eCollection 2019 Apr.

18.

Characteristics of Gay, Bisexual and Other Men Who Have Sex With Men With Multiple Diagnoses of Infectious Syphilis in British Columbia, Canada, 2005-2014.

Konrad S, Mak DB, Grennan T, Zakher B, Brownrigg B, Ogilvie G, Morshed M, Tyndall M, Gilbert M, Krajden M, Wong J.

Sex Transm Dis. 2019 Jul;46(7):423-428. doi: 10.1097/OLQ.0000000000000995.

PMID:
30870310
19.

Deriving the optimal limit of detection for an HCV point-of-care test for viraemic infection: Analysis of a global dataset.

Freiman JM, Wang J, Easterbrook PJ, Horsburgh CR, Marinucci F, White LF, Kamkamidze G, Krajden M, Loarec A, Njouom R, Nguyen KV, Shiha G, Soliman R, Solomon SS, Tsertsvadze T, Denkinger CM, Linas B.

J Hepatol. 2019 Jul;71(1):62-70. doi: 10.1016/j.jhep.2019.02.011. Epub 2019 Feb 21.

PMID:
30797050
20.

Interim estimates of 2018/19 vaccine effectiveness against influenza A(H1N1)pdm09, Canada, January 2019.

Skowronski DM, Leir S, Sabaiduc S, Murti M, Dickinson JA, Olsha R, Gubbay JB, Croxen MA, Charest H, Chan T, Bastien N, Li Y, Krajden M, De Serres G.

Euro Surveill. 2019 Jan;24(4). doi: 10.2807/1560-7917.ES.2019.24.4.1900055.

21.

Applying core theory and spatial analysis to identify hepatitis C virus infection "core areas" in British Columbia, Canada.

Butt ZA, Mak S, Gesink D, Gilbert M, Wong J, Yu A, Wong S, Alvarez M, Chong M, Buxton J, Tyndall M, Krajden M, Janjua NZ.

J Viral Hepat. 2019 Mar;26(3):373-383. doi: 10.1111/jvh.13043. Epub 2018 Dec 11.

PMID:
30447122
22.

Evaluation of a validated methylation triage signature for human papillomavirus positive women in the HPV FOCAL cervical cancer screening trial.

Cook DA, Krajden M, Brentnall AR, Gondara L, Chan T, Law JH, Smith LW, van Niekerk DJ, Ogilvie GS, Coldman AJ, Warman R, Reuter C, Cuzick J, Lorincz AT.

Int J Cancer. 2019 May 15;144(10):2587-2595. doi: 10.1002/ijc.31976. Epub 2018 Dec 24.

23.

Quasispecies Diversity Is a Major Risk Factor for Vertical Hepatitis C Virus Transmission.

Larouche A, Milton McSween KA, Calderon V, Fauteux-Daniel S, Boulais J, Ransy DG, Boucher M, Lamarre V, Lapointe N, Boucoiran I, Money DM, Krajden M, Le Campion A, Soudeyns H.

J Infect Dis. 2019 Feb 15;219(5):760-771. doi: 10.1093/infdis/jiy581.

PMID:
30365007
24.

Vaccine Effectiveness Against Lineage-matched and -mismatched Influenza B Viruses Across 8 Seasons in Canada, 2010-2011 to 2017-2018.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Fonseca K, Charest H, Martineau C, Hickman R, Chan T, Jassem A, Petric M, Rose C, Bastien N, Li Y, Krajden M.

Clin Infect Dis. 2019 May 2;68(10):1754-1757. doi: 10.1093/cid/ciy876.

25.

Should Sex Be Considered an Effect Modifier in the Evaluation of Influenza Vaccine Effectiveness?

Chambers C, Skowronski DM, Rose C, Serres G, Winter AL, Dickinson JA, Jassem A, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Petric M, Krajden M.

Open Forum Infect Dis. 2018 Sep 4;5(9):ofy211. doi: 10.1093/ofid/ofy211. eCollection 2018 Sep.

26.

Comparative performance of human papillomavirus messenger RNA versus DNA screening tests at baseline and 48 months in the HPV FOCAL trial.

Cook DA, Smith LW, Law JH, Mei W, Gondara L, van Niekerk DJ, Ceballos KM, Jang D, Chernesky M, Franco EL, Ogilvie GS, Coldman AJ, Krajden M.

J Clin Virol. 2018 Nov;108:32-37. doi: 10.1016/j.jcv.2018.09.004. Epub 2018 Sep 10.

PMID:
30223252
27.

Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals.

Butt ZA, Shrestha N, Gesink D, Murti M, Buxton JA, Gilbert M, Balshaw RF, Wong S, Kuo M, Wong J, Yu A, Alvarez M, Samji H, Roth D, Consolacion T, Hull MW, Ogilvie G, Tyndall MW, Krajden M, Janjua NZ.

Clin Epidemiol. 2018 Aug 31;10:1127-1145. doi: 10.2147/CLEP.S173449. eCollection 2018.

28.

Hepatitis C virus reinfection after successful treatment with direct-acting antiviral therapy in a large population-based cohort.

Rossi C, Butt ZA, Wong S, Buxton JA, Islam N, Yu A, Darvishian M, Gilbert M, Wong J, Chapinal N, Binka M, Alvarez M, Tyndall MW, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort Team.

J Hepatol. 2018 Nov;69(5):1007-1014. doi: 10.1016/j.jhep.2018.07.025. Epub 2018 Aug 22.

PMID:
30142429
29.

In-hospital post-transplant acute hepatitis A viral (HAV) infection in a liver transplant recipient who was HAV seropositive pre-transplant.

Zhu J, Alalkim F, Hussaini T, Erb SR, Marquez V, Krajden M, Webber D, Yoshida EM.

Saudi J Gastroenterol. 2019 Jan-Feb;25(1):67-70. doi: 10.4103/sjg.SJG_230_18.

30.

Transplanting Hepatitis C-Seropositive, Nucleic Acid Test-Negative Donor Organs Into Hepatitis C-Negative Recipients.

Hussaini T, Krajden M, Mitchell RA, Yoshida EM.

Hepatology. 2018 Sep;68(3):1208-1209. doi: 10.1002/hep.30121. No abstract available.

PMID:
30070362
31.

Estimating the impact of early hepatitis C virus clearance on hepatocellular carcinoma risk.

Darvishian M, Janjua NZ, Chong M, Cook D, Samji H, Butt ZA, Yu A, Alvarez M, Yoshida E, Ramji A, Wong J, Woods R, Tyndall M, Krajden M.

J Viral Hepat. 2018 Dec;25(12):1481-1492. doi: 10.1111/jvh.12977. Epub 2018 Aug 28.

PMID:
30047609
32.

Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.

Ogilvie GS, van Niekerk D, Krajden M, Smith LW, Cook D, Gondara L, Ceballos K, Quinlan D, Lee M, Martin RE, Gentile L, Peacock S, Stuart GCE, Franco EL, Coldman AJ.

JAMA. 2018 Jul 3;320(1):43-52. doi: 10.1001/jama.2018.7464. Erratum in: JAMA. 2018 Dec 4;320(21):2273.

33.

HIV serology signal-to-cutoff ratio as a rapid method to predict confirmation of HIV infection.

Li L, Puddicombe D, Champagne S, Jassem A, Krajden M, Merrick L, Lowe C, Payne M.

Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1589-1593. doi: 10.1007/s10096-018-3290-y. Epub 2018 Jun 3.

PMID:
29862422
34.

Transplantation of a Liver Allograft From a Hepatitis C Virus Seropositive Donor With Previous Sustained Virologic Response to an Uninfected Recipient Suffering Steroid Refractory Acute Graft Rejection With No Evidence of HCV Transmission.

Mitchell RA, Hussaini T, Yau AH, Krajden M, Wright AJ, Scudamore CH, Marquez Azalgara V, Erb SR, Yoshida EM.

Transplant Direct. 2018 Feb 2;4(3):e347. doi: 10.1097/TXD.0000000000000763. eCollection 2018 Mar.

35.

Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada.

Binka M, Butt ZA, Wong S, Chong M, Buxton JA, Chapinal N, Yu A, Alvarez M, Darvishian M, Wong J, McGowan G, Torban M, Gilbert M, Tyndall M, Krajden M, Janjua NZ.

World J Gastroenterol. 2018 Mar 21;24(11):1216-1227. doi: 10.3748/wjg.v24.i11.1216.

36.

Implementation considerations using HPV self-collection to reach women under-screened for cervical cancer in high-income settings.

Pedersen HN, Smith LW, Racey CS, Cook D, Krajden M, van Niekerk D, Ogilvie GS.

Curr Oncol. 2018 Feb;25(1):e4-e7. doi: 10.3747/co.25.3827. Epub 2018 Feb 28. No abstract available.

37.

Diagnostic Yield of Laboratory Methods and Value of Viral Genotyping during an Outbreak of Mumps in a Partially Vaccinated Population in British Columbia, Canada.

Nunn A, Masud S, Krajden M, Naus M, Jassem AN.

J Clin Microbiol. 2018 Apr 25;56(5). pii: e01954-17. doi: 10.1128/JCM.01954-17. Print 2018 May.

38.

Identifying injection drug use and estimating population size of people who inject drugs using healthcare administrative datasets.

Janjua NZ, Islam N, Kuo M, Yu A, Wong S, Butt ZA, Gilbert M, Buxton J, Chapinal N, Samji H, Chong M, Alvarez M, Wong J, Tyndall MW, Krajden M; BC Hepatitis Testers Cohort Team.

Int J Drug Policy. 2018 May;55:31-39. doi: 10.1016/j.drugpo.2018.02.001. Epub 2018 Feb 23.

PMID:
29482150
39.

Differences in experiences of barriers to STI testing between clients of the internet-based diagnostic testing service GetCheckedOnline.com and an STI clinic in Vancouver, Canada.

Gilbert M, Thomson K, Salway T, Haag D, Grennan T, Fairley CK, Buchner C, Krajden M, Kendall P, Shoveller J, Ogilvie G.

Sex Transm Infect. 2019 Mar;95(2):151-156. doi: 10.1136/sextrans-2017-053325. Epub 2018 Feb 7.

40.

Early season co-circulation of influenza A(H3N2) and B(Yamagata): interim estimates of 2017/18 vaccine effectiveness, Canada, January 2018.

Skowronski DM, Chambers C, De Serres G, Dickinson JA, Winter AL, Hickman R, Chan T, Jassem AN, Drews SJ, Charest H, Gubbay JB, Bastien N, Li Y, Krajden M.

Euro Surveill. 2018 Feb;23(5). doi: 10.2807/1560-7917.ES.2018.23.5.18-00035. Erratum in: Euro Surveill. 2018 Jul;23(30):.

41.

Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study.

Alavi M, Janjua NZ, Chong M, Grebely J, Aspinall EJ, Innes H, Valerio H, Hajarizadeh B, Hayes PC, Krajden M, Amin J, Law MG, George J, Goldberg DJ, Hutchinson SJ, Dore GJ.

J Viral Hepat. 2018 May;25(5):473-481. doi: 10.1111/jvh.12837. Epub 2018 Feb 6.

42.

The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study.

Alavi M, Janjua NZ, Chong M, Grebely J, Aspinall EJ, Innes H, Valerio HM, Hajarizadeh B, Hayes PC, Krajden M, Amin J, Law MG, George J, Goldberg DJ, Hutchinson SJ, Dore GJ.

J Hepatol. 2018 Mar;68(3):393-401. doi: 10.1016/j.jhep.2017.10.019. Epub 2017 Oct 26.

PMID:
29107152
43.

Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015-2016 Season in Canada.

Skowronski DM, Chambers C, Sabaiduc S, De Serres G, Winter AL, Dickinson JA, Gubbay JB, Drews SJ, Martineau C, Charest H, Krajden M, Bastien N, Li Y.

J Infect Dis. 2017 Dec 19;216(12):1487-1500. doi: 10.1093/infdis/jix526.

44.

Post-Loop Electrosurgical Excision Procedure High-Risk Human Papillomavirus Testing as a Test of Cure: The British Columbia Experience.

Ceballos KM, Lee M, Cook DA, Smith LW, Gondara L, Krajden M, van Niekerk DJ, Coldman AJ.

J Low Genit Tract Dis. 2017 Oct;21(4):284-288. doi: 10.1097/LGT.0000000000000349.

PMID:
28953120
45.

Hepatitis C cross-genotype immunity and implications for vaccine development.

Islam N, Krajden M, Shoveller J, Gustafson P, Gilbert M, Wong J, Tyndall MW, Janjua NZ; The BC-HTC Team.

Sci Rep. 2017 Sep 26;7(1):12326. doi: 10.1038/s41598-017-10190-8.

46.

Age-Related Differences in Influenza B Infection by Lineage in a Community-Based Sentinel System, 2010-2011 to 2015-2016, Canada.

Skowronski DM, Chambers C, De Serres G, Sabaiduc S, Winter AL, Dickinson JA, Gubbay JB, Fonseca K, Drews SJ, Charest H, Martineau C, Krajden M, Petric M, Bastien N, Li Y.

J Infect Dis. 2017 Sep 15;216(6):697-702. doi: 10.1093/infdis/jix393.

47.

Measles Lymphadenopathy in a Child With PFAPA Syndrome.

Terry J, Brown K, Hiebert J, Al-Rawahi GN, Moxham JP, Krajden M, Jassem AN, Tucker L.

Pediatr Dev Pathol. 2018 Sep-Oct;21(5):497-501. doi: 10.1177/1093526617727970. Epub 2017 Sep 7.

PMID:
28882091
48.

Treatment outcomes for isoniazid-resistant tuberculosis under program conditions in British Columbia, Canada.

Romanowski K, Chiang LY, Roth DZ, Krajden M, Tang P, Cook VJ, Johnston JC.

BMC Infect Dis. 2017 Sep 4;17(1):604. doi: 10.1186/s12879-017-2706-0.

50.

A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia.

Butt ZA, Shrestha N, Wong S, Kuo M, Gesink D, Gilbert M, Wong J, Yu A, Alvarez M, Samji H, Buxton JA, Johnston JC, Cook VJ, Roth D, Consolacion T, Murti M, Hottes TS, Ogilvie G, Balshaw R, Tyndall MW, Krajden M, Janjua NZ; BC Hepatitis Testers Cohort.

PLoS One. 2017 Aug 22;12(8):e0183609. doi: 10.1371/journal.pone.0183609. eCollection 2017.

Supplemental Content

Loading ...
Support Center